Anavex Life Sciences Corp. (AVXL) News
Follow Anavex Life Sciences Corp. (AVXL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 19 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
AVXL - Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting
AVXL - Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting
NEWS | Sep 24, 2026, 02:01 PM UTC
M
Anavex to discuss pediatric inclusion in Phase 3 Rett trial
Anavex said the FDA granted a meeting to discuss including pediatric patients in its Phase 3 Rett syndrome trial for ANAVEX 2-73.
EQUITY | Sep 09, 2026, 09:24 PM UTC
L
AVXL: Prioritizing core CNS programs and restoring compliance, with a focus on transparency and execution
Regained Nasdaq compliance and addressed internal control weaknesses, with a renewed focus on transparency and disciplined execution. Prioritizing blarcamesine development for Alzheimer's, Rett syndrome, and Fragile X sy
EQUITY | Sep 09, 2026, 08:55 PM UTC
L
AVXL regains Nasdaq compliance and refocuses on three core indications
AVXL says it regained Nasdaq compliance and addressed internal control weaknesses, focusing resources on Alzheimer's, Rett syndrome and fragile X syndrome. The company is advancing blarcamesine with regulatory engagement
EQUITY | Sep 09, 2026, 08:34 PM UTC
L
PVG calls to replace Anavex board and hire experienced CEO
PVG called for replacing Anavex Life Sciences Corp’s board and hiring an “experienced” CEO.
EQUITY | Sep 09, 2026, 04:41 PM UTC
L
Anavex Life Sciences schedules investor call for Sept. 9, 2026
Anavex Life Sciences Corp. said it will host an investor call on Wednesday, September 9, 2026, at 4:00 PM ET.
EQUITY | Sep 08, 2026, 12:07 PM UTC
L
AVXL to host investor call Wednesday, Sept. 9 at 4:00 PM ET
Anavex Life Sciences (AVXL) will host an investor call on Wednesday, September 9, 2026, at 4:00 PM ET.
EQUITY | Sep 08, 2026, 12:01 PM UTC
L
Pvg Asset Management nominates six director candidates for AVXL board
Pvg Asset Management has nominated six director candidates for Anavex Life Sciences Corp’s board.
EQUITY | Sep 03, 2026, 09:54 PM UTC
L
Anavex regains Nasdaq compliance after delayed 10-Q filings
Anavex Life Sciences regained Nasdaq compliance after filing its delayed Form 10-Qs for March 31 and June 30, 2026.
REGULATION | Sep 02, 2026, 09:14 PM UTC
L
Anavex Life Sciences regains Nasdaq filing compliance
Anavex Life Sciences Corp has regained compliance with Nasdaq’s periodic filing requirement.
EQUITY | Sep 02, 2026, 08:09 PM UTC
L
AVXL regains Nasdaq periodic filing compliance
Anavex Life Sciences (AVXL) has regained compliance with Nasdaq’s periodic filing requirement.
EQUITY | Sep 02, 2026, 08:00 PM UTC
L
AVXL reports Q3 2026 net income of $7.8M
AVXL said Q3 2026 net income reached $7.8M.
EARNINGS | Aug 31, 2026, 08:43 PM UTC
L
AVXL: Net loss narrowed on lower R&D costs; strong cash, but leadership and compliance risks persist
AVXL: Net loss narrowed on lower R&D costs; strong cash, but leadership and compliance risks persist
EQUITY | Aug 28, 2026, 08:34 PM UTC
M
Anavex (AVXL) reports Third Fiscal Quarter 2026 results
Anavex Life Sciences (AVXL) reports Third Fiscal Quarter 2026 financial results and provides a business update.
EQUITY | Aug 25, 2026, 12:01 PM UTC
L
Anavex Life Sciences mails stockholder letter on six director nominees
Anavex Life Sciences (AVXL) mails a letter to stockholders reinforcing the relevant experience of all six director nominees, according to TradeXchange Newsdesk.
REGULATION | Aug 17, 2026, 12:01 PM UTC
L
AVXL Anavex Life Sciences Corp - nominates gautam Patel and adrian senderowicz as Independent directors - Urges stockholders to reject pvg a
AVXL Anavex Life Sciences Corp - nominates gautam Patel and adrian senderowicz as Independent directors - Urges stockholders to reject pvg asset management and Patrick s. Adams control attempt - Christopher missling and
REGULATION | Aug 03, 2026, 12:04 PM UTC
M
Anavex Life Sciences Refreshes Board
Anavex Life Sciences updates board for progress
EQUITY | Aug 03, 2026, 12:01 PM UTC
L
AVXL Anavex Life Sciences RESULTS: Q3, Q3 Net Income $-5.3M, Q3 EPS $-0.06
AVXL Anavex Life Sciences RESULTS: Q3, Q3 Net Income $-5.3M, Q3 EPS $-0.06
EARNINGS | Jul 30, 2026, 12:01 PM UTC
L
AVXL - Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update
AVXL - Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Jul 30, 2026, 12:00 PM UTC